Arthur M. Krieg - 28 May 2021 Form 4 Insider Report for Checkmate Pharmaceuticals, Inc. (CMPI)

Role
Chief Scientific Officer
Signature
/s/ Katherine Eade, attorney-in-fact
Issuer symbol
CMPI
Transactions as of
28 May 2021
Transactions value $
$0
Form type
4
Filing time
01 Jun 2021, 18:44:18 UTC
Previous filing
19 May 2021
Next filing
17 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMPI Common Stock Other $0 -68,457 -100% $0* 0 28 May 2021 See footnote F1
transaction CMPI Common Stock Other $0 -68,457 -100% $0* 0 28 May 2021 See footnote F1
transaction CMPI Common Stock Other $0 -68,457 -100% $0* 0 28 May 2021 See footnote F1
holding CMPI Common Stock 804,932 28 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were held by an irrevocable trust for the Reporting Person's child. The Reporting Person serves as trustee of the trust, which is being dissolved at the discretion of the trustee . On May 28, 2021, share ownership of the 68,457 shares of common stock which were held in the trust, for which the Reporting Person had previously disclaimed beneficial ownership of, were transferred to the Reporting Person's adult child, the beneficiary of the trust, who does not live in the same household as the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney